OC
PFE icon

Optimas Capital’s Pfizer PFE Stock Holding History

Optimas Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.79M Buy
+170,700
New +$4.54M 10.76% 4
2025
Q4 		– Sell
-220,800
Closed -$5.63M – 33
2025
Q3 		$5.63M Buy
+220,800
New +$5.45M 3.56% 12

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Optimas Capital's PFE Position: Q1 2026 in Review

Optimas Capital opened a new position in Pfizer (PFE) in Q1 2026: 170,700 shares worth $4.79M. The stake represents 10.76% of the portfolio and ranks #4 among its holdings. This is a return to the name: Optimas Capital previously reported a position in PFE as recently as Q3 2025.

Optimas Capital first reported a position in PFE in Q3 2025 and has held it in 2 quarters since. The position peaked at $5.63M in Q3 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Optimas Capital held 170,700 shares of Pfizer worth $4.79M as of Q1 2026.
  • Pfizer was a new Optimas Capital position in Q1 2026.
  • Pfizer made up 10.76% of Optimas Capital's portfolio in Q1 2026, its #4 holding.
  • Optimas Capital first reported a position in Pfizer in Q3 2025 and has held it in 2 quarters since.
  • Optimas Capital's Pfizer position peaked at $5.63M in Q3 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Optimas Capital's 13F filing for Q1 2026, filed 7 May 2026.